The National Agency for Food and Drug Administration and Control, NAFDAC, has approved the use of the Gardasil vaccine as a single dose in the routine immunization against cervical cancer. In a joint statement by NAFDAC and the National Primary Health Care Development Agency (NPHCDA), the
